[Cardiotoxicity induced by 5-fluorouracil or capecitabine]

Ugeskr Laeger. 2010 Jan 4;172(1):48-51.
[Article in Danish]

Abstract

5-fluorouracil and capecitabine have significant antineoplastic activity towards various solid tumors. Cardiotoxicity causing angina, arrhythmia and infarction are serious adverse events associated with these agents. The pathogenesis is discussed and symptoms of cardiotoxicity, intervention with nitroglycerine and risk factors as cardiac comorbidity are described. Following cardiotoxicity, lack of alternative active agents may provide grounds to rechallenge with 5-FU. In this situation, dose-modified 5-FU-based chemotherapy supported by medical antiangina prevention is feasible.

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / metabolism
  • Capecitabine
  • Colorectal Neoplasms / drug therapy
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / metabolism
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects*
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / metabolism
  • Heart / drug effects*
  • Heart Diseases / chemically induced*
  • Heart Diseases / prevention & control
  • Humans
  • Isosorbide Dinitrate / administration & dosage
  • Isosorbide Dinitrate / analogs & derivatives
  • Nitroglycerin / administration & dosage
  • Prodrugs
  • Risk Factors
  • Vasodilator Agents / administration & dosage

Substances

  • Antimetabolites, Antineoplastic
  • Prodrugs
  • Vasodilator Agents
  • Deoxycytidine
  • Capecitabine
  • Nitroglycerin
  • Isosorbide Dinitrate
  • isosorbide-5-mononitrate
  • Fluorouracil